Department of Gynecology and Obstetrics, Clemenshospital Muenster, Münster, Germany.
Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
Arch Gynecol Obstet. 2024 Aug;310(2):655-672. doi: 10.1007/s00404-024-07584-1. Epub 2024 Jun 15.
The formation of adhesions after gynecological surgery not only has detrimental impacts on those affected, including pain, obstruction, and infertility, but also imposes a high economic burden on healthcare systems worldwide.
The aim of this review was to evaluate the adhesion prevention potential of all currently available adhesion barriers for gynecological surgery.
We systematically searched MEDLINE and CENTRAL databases for randomized controlled trials (RCTs) on the use of adhesion barriers as compared with peritoneal irrigation or no treatment in gynecological surgery. Only RCTs with second-look surgery to evaluate adhesions in the pelvic/abdominal (but not intrauterine) cavity were included.
We included 45 RCTs with a total of 4,120 patients examining a total of 10 unique types of barriers in second-look gynecological surgery. While RCTs on oxidized regenerated cellulose (significant improvement in 6 of 14 trials), polyethylene glycol with/without other agents (4/10), hyaluronic acid and hyaluronate + carboxymethylcellulose (7/10), icodextrin (1/3), dextran (0/3), fibrin-containing agents (1/2), expanded polytetrafluoroethylene (1/1), N,O-carboxymethylchitosan (0/1), and modified starch (1/1) overall showed inconsistent findings, results for expanded polytetrafluoroethylene, hyaluronic acid, and modified starch yielded the greatest improvements regarding adhesion reduction at 75%, 0-67%, and 85%, respectively.
Best results for adhesion prevention were reported after applying Gore-Tex Surgical Membrane, hyaluronic acid, and 4DryField. As Gore-Tex Surgical Membrane is nonabsorbable, it is associated with a greater risk of new adhesion formation due to second-look surgery to remove the product. 4DryField yielded the greatest improvement in adhesion score compared to all other barrier agents (85%). For better comparability, future studies should use standardized scores and put more emphasis on patient-reported outcome measures, such as pain and infertility.
妇科手术后粘连的形成不仅对受影响者造成不利影响,包括疼痛、阻塞和不孕,而且给全球医疗保健系统带来了沉重的经济负担。
本综述旨在评估目前可用于妇科手术的所有粘连预防屏障的预防粘连效果。
我们系统地检索了 MEDLINE 和 CENTRAL 数据库,以评估与腹膜冲洗或不治疗相比,在妇科手术中使用粘连屏障的效果。仅纳入了在盆腔/腹部(而非子宫内)腔进行二次探查手术以评估粘连的随机对照试验(RCT)。
我们纳入了 45 项 RCT,共纳入 4120 名患者,在二次探查妇科手术中总共评估了 10 种不同类型的屏障。虽然氧化再生纤维素(6/14 项试验中显著改善)、聚乙二醇加/不加其他制剂(4/10)、透明质酸和透明质酸盐+羧甲基纤维素(7/10)、艾考糊精(1/3)、右旋糖酐(0/3)、含纤维蛋白制剂(1/2)、膨化聚四氟乙烯(1/1)、N,O-羧甲基壳聚糖(0/1)和改性淀粉(1/1)的 RCT 结果不一致,但膨化聚四氟乙烯、透明质酸和改性淀粉在减少粘连方面的结果分别为 75%、0-67%和 85%,效果最好。
应用 Gore-Tex Surgical Membrane、透明质酸和 4DryField 后报告了预防粘连的最佳结果。由于 Gore-Tex Surgical Membrane 不可吸收,因此由于去除产品的二次探查手术,它与形成新粘连的风险更大。与所有其他屏障剂相比,4DryField 使粘连评分的改善最大(85%)。为了更好地进行比较,未来的研究应使用标准化评分,并更加重视患者报告的结果测量,如疼痛和不孕。